NFE2L2 and Parkinson disease: The studies revealed that the Nrf2 signaling is dysregulated in a variety of CNS-related disorders, especially neurodegenerative diseases, such as AD & PD (171), Friedreich’s Ataxia (172), and Huntington’s disease (173).